EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention

Krishnaraju Madavaraju iD, Tejabhiram Yadavalli iD, Sudhanshu Kumar Singh, Chandrashekhar D Patil iD, Hemant Borase, Deepak Shukla iD

mBio · 2026

DOI: 10.1128/mbio.03741-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Krishnaraju Madavaraju und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, University of Illinois Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Virus Replication, Antiviral Agents, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex virus type 1 (HSV-1) poses a persistent public health challenge, particularly due to the emergence of drug-resistant strains and the limited efficacy of current monotherapies. Through an unbiased multi-omic approach, we identify a previously lesser-known viral strategy in which HSV-1 hijacks cyclin-dependent kinase (CDK) signaling to disrupt host cell cycle and translational control, specifically via the eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1). Targeted knockdown of CDKs confirmed their critical role in mediating 4EBP1 dephosphorylation during infection. Mechanistic evaluation of BX795, a previously known modulator of the 4EBP1 pathway, revealed an alternative route of translational repression mediated through CDKs. To further support this conclusion, we demonstrated that a distinct small-molecule CDK inhibitor, GW8510, exhibits potent antiviral activity against HSV-1 and functions as a true mechanistic analog of BX795. Together, these findings uncover a previously unrecognized CDK-4EBP1 regulatory axis exploited by HSV-1 and identify GW8510 as a promising candidate for host-directed antiviral intervention. IMPORTANCE Herpes simplex virus type 1 remains a major clinical burden, and resistance to existing therapies underscores the need for alternative strategies. This study reveals a mechanism by which HSV-1 regulates host cell cycle and translation control through cyclin-dependent kinase signaling and the 4E-binding protein 1 pathway. By revealing that pharmacological inhibition of this pathway suppresses viral replication, we identify a host-directed therapeutic approach that circumvents challenges associated with viral resistance to the current drugs. The demonstration of potent antiviral activity by GW8510, a small-molecule cyclin-dependent kinase inhibitor, establishes a promising foundation for translational development and highlights the potential of targeting host regulatory networks to combat viral infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, HumanVirus ReplicationAntiviral AgentsSignal TransductionCell Cycle ProteinsAdaptor Proteins, Signal TransducingCyclin-Dependent KinasesPhosphoproteinsHumansAnimalsHost-Pathogen InteractionsPhosphorylationHerpes SimplexHost-Directed TherapyOxazolesThiazoles

Stichwörter der Autor:innen

4EBP1BX795CDKGW8510herpes simplex virus-1 (HSV-1)

Substanzen

Antiviral AgentsCell Cycle ProteinsEIF4EBP1 protein, humanAdaptor Proteins, Signal TransducingCyclin-Dependent KinasesPhosphoproteinsN-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamideOxazolesThiazoles

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Science, University of Illinois Chicago, Chicago, Illinois, USA.
  • Department of Microbiology and Immunology, College of Medicine, University of Illinois Chicago, Chicago, Illinois, USA.

ORCID-Profile: Krishnaraju Madavaraju, Tejabhiram Yadavalli, Chandrashekhar D Patil, Deepak Shukla

Förderung

  • NEI NIH HHS
  • National Eye Institute

Zitieren

APA

Madavaraju, K., Yadavalli, T., Singh, S. K., Patil, C. D., Borase, H., & Shukla, D. (2026). A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention. mBio. https://doi.org/10.1128/mbio.03741-25

Vancouver

Madavaraju K, Yadavalli T, Singh SK, Patil CD, Borase H, Shukla D. A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention. mBio. 2026. doi:10.1128/mbio.03741-25

BibTeX
@article{Madavaraju2026,
  author = {Madavaraju, Krishnaraju and Yadavalli, Tejabhiram and Singh, Sudhanshu Kumar and Patil, Chandrashekhar D and Borase, Hemant and Shukla, Deepak},
  title = {A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention},
  journal = {mBio},
  year = {2026},
  doi = {10.1128/mbio.03741-25}
}
Kostenlos starten →